Research ArticleFOXP3+ T Regulatory Cell Modifications in Inflammatory Bowel Disease Patients Treated with Anti-TNF Agents
Figure 2
(a) “Treg responders” and “Treg nonresponders” among all IBD clinical responders; value by test. (b) Treg response in clinical nonresponder patients.